FibroBiologics Inc. License Agreements
5 Contracts & Agreements
- Amendment No. 4, effective January 1, 2023, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
- Amendment No. 3, effective October 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
- Amendment No. 2, effective August 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
- Amendment No. 1, effective July 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
- License Agreement, dated November 30, 2021, between K2 Biolabs, LLC and FibroBiologics, LLC (Filed With SEC on November 28, 2023)
